glp-1 agonist anxiety side effects Part 2 of a 3-Part Series; Medications for Weight Loss GLP-1s associated with reduced risk
Description
Others said they smoked less or lost the urge to gamble

NLRP3: Nod-like receptor protein 3
Any GLP-1 program should be considered part of a broader approach that includes dietary and activity modifications

Tereak P, Lapao A, Subic N, Boya P, Elazar Z, Simonsen A

As mentioned, GLP-1s may affect areas of the brain that underlie reward and motivated behavior

Transdermal delivery works well for small, lipophilic (fat-soluble) molecules with specific molecular weights that can penetrate skin effectively